Circulating levels of interleukin-6 in patients with hormone refractory prostate cancer

1999280 citationsJournal Article

Authors

Abdel‐Aziz A. Elgamal · Northwest Hospital

Abstract

Serum IL-6 levels are significantly elevated in hormone-refractory prostate cancer patients and may be a surrogate marker of the androgen independent phenotype.

Topics & Keywords

Prostate Cancer Treatment and Research Prostate Cancer Diagnosis and Treatment Cancer, Lipids, and Metabolism

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: The Prostate

Volume 41, Issue 2, pp. 127-133

DOI: 10.1002/(sici)1097-0045(19991001)41:2<127::aid-pros7>3.0.co;2-h

Field-Weighted Citation Impact: 7.57